JP Morgan Private Wealth Advisors’s Ascendis Pharma A/S ASND Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.81M	Buy	+19,325	New	+$1.81M	0.01%	776
2023 Q2	–	Sell	-12,929	Closed	-$1.39M	–	1497
2023 Q1	$1.39M	Sell	12,929 -104,394	-89%	-$11.9M	﹤0.01%	1021
2022 Q4	$14.3M	Buy	117,323 +102,323	+682%	+$11.9M	0.03%	357
2022 Q3	$1.55M	Buy	15,000 +2,215	+17%	+$210K	﹤0.01%	939
2022 Q2	$1.19M	Sell	12,785 -920	-7%	-$86.7K	﹤0.01%	1044
2022 Q1	$1.61M	Sell	13,705 -9,190	-40%	-$1.06M	﹤0.01%	987
2021 Q4	$3.08M	Buy	22,895 +1,408	+7%	+$209K	0.01%	764
2021 Q3	$3.42M	Buy	21,487 +4,220	+24%	+$578K	0.01%	695
2021 Q2	$2.27M	Buy	17,267 +10,017	+138%	+$1.33M	0.01%	821
2021 Q1	$934K	Sell	7,250 -70,538	-91%	-$10.7M	﹤0.01%	1073
2020 Q4	$13M	Buy	77,788 +27,057	+53%	+$4.47M	0.04%	329
2020 Q3	$7.83M	Buy	50,731 +46,229	+1,027%	+$6.65M	0.03%	363
2020 Q2	$666K	Buy	+4,502	New	+$618K	﹤0.01%	964

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ASND Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors opened a new position in Ascendis Pharma A/S (ASND) in Q3 2023: 19,325 shares worth $1.81M. The stake represents 0.01% of the portfolio and ranks #776 among its holdings. This is a return to the name: JP Morgan Private Wealth Advisors previously reported a position in ASND as recently as Q1 2023.

JP Morgan Private Wealth Advisors first reported a position in ASND in Q2 2020 and has held it in 13 quarters since. The position peaked at $14.3M in Q4 2022. 160 funds tracked by Wall St. Rank hold ASND as of Q3 2023.

JP Morgan Private Wealth Advisors held 19,325 shares of Ascendis Pharma A/S worth $1.81M as of Q3 2023.
Ascendis Pharma A/S was a new JP Morgan Private Wealth Advisors position in Q3 2023.
Ascendis Pharma A/S made up 0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #776 holding.
JP Morgan Private Wealth Advisors first reported a position in Ascendis Pharma A/S in Q2 2020 and has held it in 13 quarters since.
JP Morgan Private Wealth Advisors's Ascendis Pharma A/S position peaked at $14.3M in Q4 2022.
160 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.